Cellular and physiological roles for phospholipase D1 in cancer

Journal of Biological Chemistry

Volumn 289, Issue 33, 2014, Pages 22567-22574

  Zhang, Yi ^a   Frohman, Michael A ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMORS;

ANGIOGENESIS; IN-VIVO; MULTIPLE CELLS; PHOSPHOLIPASE D; PHOSPHOLIPASES; PHYSIOLOGICAL ROLES; SMALL MOLECULES; TUMOR CELLS;

DISEASES;

5 FLUORO 2 INDOLYL DES CHLOROHALOPEMIDE; CERAMIDE; NEOMYCIN; PHOSPHODIESTERASE INHIBITOR; PHOSPHOLIPASE D INHIBITOR; PHOSPHOLIPASE D1; PHOSPHOLIPASE D1 INHIBITOR; PHOSPHOLIPASE D2 INHIBITOR; UNCLASSIFIED DRUG; ENZYME INHIBITOR; PHOSPHOLIPASE D;

ANGIOGENESIS; ENZYME ACTIVITY; HUMAN; IN VIVO STUDY; METASTASIS; MOUSE STRAIN; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; TUMOR CELL; TUMOR MICROENVIRONMENT; ANIMAL; ANTAGONISTS AND INHIBITORS; ENZYMOLOGY; GENETICS; METABOLISM; MOUSE; MUTANT MOUSE STRAIN; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY;

ANIMALS; ENZYME INHIBITORS; HUMANS; MICE; MICE, MUTANT STRAINS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHOLIPASE D; TUMOR MICROENVIRONMENT;

EID: 84905980787     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.R114.576876     Document Type: Short Survey

References (104)

1. Jenkins, G. M., and Frohman, M. A. (2005) Phospholipase D: a lipid centric review. Cell. Mol. Life Sci. 62, 2305-2316 (Pubitemid 41500546)
2. Hammond, S. M., Altshuller, Y. M., Sung, T. C., Rudge, S. A., Rose, K., Engebrecht, J., Morris, A. J., and Frohman, M. A. (1995) Human ADP-ribosylation factor-activated phosphatidylcholine-specific phospholipase D defines a new and highly conserved gene family. J. Biol. Chem. 270, 29640-29643 (Pubitemid 26001622)
3. Colley, W. C., Sung, T. C., Roll, R., Jenco, J., Hammond, S. M., Altshuller, Y., Bar-Sagi, D., Morris, A. J., and Frohman, M. A. (1997) Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr. Biol. 7, 191-201 (Pubitemid 27164725)
4. Redina, O. E., and Frohman, M. A. (1998) Genomic analysis of murine phospholipase D1 and comparison to phospholipase D2 reveals an unusual difference in gene size. Gene 222, 53-60 (Pubitemid 28566151)
5. Redina, O. E., and Frohman, M. A. (1998) Organization and alternative splicing of the murine phospholipase D2 gene. Biochem. J. 331, 845-851 (Pubitemid 28211908)
6. Kinchen, J. M., Doukoumetzidis, K., Almendinger, J., Stergiou, L., Tosello-Trampont, A., Sifri, C. D., Hengartner, M. O., and Ravichandran, K. S. (2008) A pathway for phagosome maturation during engulfment of apoptotic cells. Nat. Cell Biol. 10, 556-566 (Pubitemid 351627375)
7. LaLonde, M. M., Janssens, H., Rosenbaum, E., Choi, S. Y., Gergen, J. P., Colley, N. J., Stark, W. S., and Frohman, M. A. (2005) Regulation of phototransduction responsiveness and retinal degeneration by a phospholipase D-generated signaling lipid. J. Cell Biol. 169, 471-479 (Pubitemid 40686697)
8. Cheol Son, J., Woo Kang, D., Mo Yang, K., Choi, K. Y., Gen Son, T., and Min do, S. (2013) Phospholipase D inhibitor enhances radiosensitivity of breast cancer cells. Exp. Mol. Med. 45, e38
9. Ye, Q., Kantonen, S., Henkels, K. M., and Gomez-Cambronero, J. (2013) A new signaling pathway (JAK-Fes-phospholipase D) that is enhanced in highly proliferative breast cancer cells. J. Biol. Chem. 288, 9881-9891
10. Zhong, M., Shen, Y., Zheng, Y., Joseph, T., Jackson, D., and Foster, D. A. (2003) Phospholipase D prevents apoptosis in v-Src-transformed rat fibroblasts and MDA-MB-231 breast cancer cells. Biochem. Biophys. Res. Commun. 302, 615-619 (Pubitemid 36279575)
11. Bruntz, R. C., Taylor, H. E., Lindsley, C. W., and Brown, H. A. (2014) Phospholipase D2 mediates survival signaling through direct regulation of Akt in glioblastoma cells. J. Biol. Chem. 289, 600-616
12. Gloerich, M., ten Klooster, J. P., Vliem, M. J., Koorman, T., Zwartkruis, F. J., Clevers, H., and Bos, J. L. (2012) Rap2A links intestinal cell polarity to brush border formation. Nat. Cell Biol. 14, 793-801
13. Nishikimi, A., Fukuhara, H., Su, W., Hongu, T., Takasuga, S., Mihara, H., Cao, Q., Sanematsu, F., Kanai, M., Hasegawa, H., Tanaka, Y., Shibasaki, M., Kanaho, Y., Sasaki, T., Frohman, M. A., and Fukui, Y. (2009) Sequential regulation of DOCK2 dynamics by two phospholipids during neutrophil chemotaxis. Science 324, 384-387
14. Sulzmaier, F. J., Valmiki, M. K., Nelson, D. A., Caliva, M. J., Geerts, D., Matter, M. L., White, E. P., and Ramos, J. W. (2012) PEA-15 potentiates H-Ras-mediated epithelial cell transformation through phospholipase D. Oncogene 31, 3547-3560
15. Buchanan, F. G., McReynolds, M., Couvillon, A., Kam, Y., Holla, V. R., Dubois, R. N., and Exton, J. H. (2005) Requirement of phospholipase D1 activity in H-RasV12-induced transformation. Proc. Natl. Acad. Sci. U.S.A. 102, 1638-1642 (Pubitemid 40209220)
16. Zhang, F., Wang, Z., Lu, M., Yonekubo, Y., Liang, X., Zhang, Y., Wu, P., Zhou, Y., Grinstein, S., Hancock, J. F., and Du, G. (2014) Temporal production of the signaling lipid phosphatidic Acid by phospholipase D2 determines the output of extracellular signal-regulated kinase signaling in cancer cells. Mol. Cell. Biol. 34, 84-95
17. Henkels, K. M., Mahankali, M., and Gomez-Cambronero, J. (2013) Increased cell growth due to a new lipase-GEF (Phospholipase D2) fastly acting on Ras. Cell. Signal. 25, 198-205
18. Mor, A., Campi, G., Du, G., Zheng, Y., Foster, D. A., Dustin, M. L., and Philips, M. R. (2007) The lymphocyte function-associated antigen-1 receptor costimulates plasma membrane Ras via phospholipase D2. Nat. Cell Biol. 9, 713-719 (Pubitemid 47214735)
19. Zhao, C., Du, G., Skowronek, K., Frohman, M. A., and Bar-Sagi, D. (2007) Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos. Nat. Cell Biol. 9, 706-712
20. Pye, D. S., Rubio, I., Pusch, R., Lin, K., Pettitt, A. R., and Till, K. J. (2013) Chemokine unresponsiveness of chronic lymphocytic leukemia cells results from impaired endosomal recycling of Rap1 and is associated with a distinctive type of immunological anergy. J. Immunol. 191, 1496-1504
21. Ali, W. H., Chen, Q., Delgiorno, K. E., Su, W., Hall, J. C., Hongu, T., Tian, H., Kanaho, Y., Di Paolo, G., Crawford, H. C., and Frohman, M. A. (2013) Deficiencies of the lipid-signaling enzymes phospholipase D1 and D2 alter cytoskeletal organization, macrophage phagocytosis, and cytokine-stimulated neutrophil recruitment. PLoS One 8, e55325
22. Chen, Q., Hongu, T., Sato, T., Zhang, Y., Ali, W., Cavallo, J. A., van der Velden, A., Tian, H., Di Paolo, G., Nieswandt, B., Kanaho, Y., and Frohman, M. A. (2012) Key roles for the lipid signaling enzyme phospholipase D1 in the tumor microenvironment during tumor angiogenesis and metastasis. Sci. Signal. 5, ra79
23. Kim, J. H., Kim, H. W., Jeon, H., Suh, P. G., and Ryu, S. H. (2006) Phospholipase D1 regulates cell migration in a lipase activity-independent manner. J. Biol. Chem. 281, 15747-15756 (Pubitemid 43848464)
24. Lehman, N., Di Fulvio, M., McCray, N., Campos, I., Tabatabaian, F., and Gomez-Cambronero, J. (2006) Phagocyte cell migration is mediated by phospholipases PLD1 and PLD2. Blood 108, 3564-3572
25. Wallert, M., McCoy, A., Voog, J., Rastedt, D., Taves-Patterson, J., Korpi-Steiner, N., Canine, J., Ngyuen, T., Nguyen, C., and Provost, J. (2011) α1-Adrenergic receptor-induced cytoskeletal organization and cell motility in CCL39 fibroblasts requires phospholipase D1. J. Cell. Biochem. 112, 3025-3034
26. Zhang, Q., Wang, D., Kundumani-Sridharan, V., Gadiparthi, L., Johnson, D. A., Tigyi, G. J., and Rao, G. N. (2010) PLD1-dependent PKCγ activation downstream to Src is essential for the development of pathologic retinal neovascularization. Blood 116, 1377-1385
27. Ahn, M. J., Park, S. Y., Kim, W. K., Cho, J. H., Chang, B. J., Kim, D. J., Ahn, J. S., Park, K., and Han, J. S. (2012) A single nucleotide polymorphism in the phospholipase D1 gene is associated with risk of non-small cell lung cancer. Int. J. Biomed. Sci. 8, 121-128
28. Cao, M. D., Döpkens, M., Krishnamachary, B., Vesuna, F., Gadiya, M. M., Lønning, P. E., Bhujwalla, Z. M., Gribbestad, I. S., and Glunde, K. (2012) Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer. NMR Biomed. 25, 1033-1042
29. Dhingra, S., Rodriguez, M. E., Shen, Q., Duan, X., Stanton, M. L., Chen, L., Zhang, R., and Brown, R. E. (2011) Constitutive activation with over-expression of the mTORC2-phospholipase D1 pathway in uterine leiomyosarcoma and STUMP: morphoproteomic analysis with therapeutic implications. Int. J. Clin. Exp. Pathol. 4, 134-146
30. Gozgit, J. M., Pentecost, B. T., Marconi, S. A., Ricketts-Loriaux, R. S., Otis, C. N., and Arcaro, K. F. (2007) PLD1 is overexpressed in an ER-negative MCF-7 cell line variant and a subset of phospho-Akt-negative breast carcinomas. Br. J. Cancer 97, 809-817 (Pubitemid 47396281)
31. Noh, D. Y., Ahn, S. J., Lee, R. A., Park, I. A., Kim, J. H., Suh, P. G., Ryu, S. H., Lee, K. H., and Han, J. S. (2000) Overexpression of phospholipase D1 in human breast cancer tissues. Cancer Lett. 161, 207-214
32. Shen, Q., Stanton, M. L., Feng, W., Rodriguez, M. E., Ramondetta, L., Chen, L., Brown, R. E., and Duan, X. (2010) Morphoproteomic analysis reveals an overexpressed and constitutively activated phospholipase D1-mTORC2 pathway in endometrial carcinoma. Int. J. Clin. Exp. Pathol. 4, 13-21
33. Vaarala, M. H., Porvari, K., Kyllönen, A., and Vihko, P. (2000) Differentially expressed genes in two LNCaP prostate cancer cell lines reflecting changes during prostate cancer progression. Lab. Invest. 80, 1259-1268 (Pubitemid 30637066)
34. Elvers, M., Stegner, D., Hagedorn, I., Kleinschnitz, C., Braun, A., Kuijpers, M. E., Boesl, M., Chen, Q., Heemskerk, J. W., Stoll, G., Frohman, M. A., and Nieswandt, B. (2010) Impaired αIIbβ3 integrin activation and shear-dependent thrombus formation in mice lacking phospholipase D1. Sci. Signal. 3, ra1
35. Stegner, D., Thielmann, I., Kraft, P., Frohman, M. A., Stoll, G., and Nieswandt, B. (2013) Pharmacological inhibition of phospholipase D protects mice from occlusive thrombus formation and ischemic stroke: brief report. Arterioscler. Thromb. Vasc. Biol. 33, 2212-2217
36. Thielmann, I., Stegner, D., Kraft, P., Hagedorn, I., Krohne, G., Kleinschnitz, C., Stoll, G., and Nieswandt, B. (2012) Redundant functions of phospholipases D1 and D2 in platelet α-granule release. J. Thromb. Haemost. 10, 2361-2372
37. Zeng, X. X., Zheng, X., Xiang, Y., Cho, H. P., Jessen, J. R., Zhong, T. P., Solnica-Krezel, L., and Brown, H. A. (2009) Phospholipase D1 is required for angiogenesis of intersegmental blood vessels in zebrafish. Dev. Biol. 328, 363-376
38. Bocckino, S. B., Wilson, P. B., and Exton, J. H. (1987) Ca2+-mobilizing hormones elicit phosphatidylethanol accumulation via phospholipase D activation. FEBS Lett. 225, 201-204
39. Sung, T. C., Roper, R. L., Zhang, Y., Rudge, S. A., Temel, R., Hammond, S. M., Morris, A. J., Moss, B., Engebrecht, J., and Frohman, M. A. (1997) Mutagenesis of phospholipase D defines a superfamily including a trans-Golgi viral protein required for poxvirus pathogenicity. EMBO J. 16, 4519-4530 (Pubitemid 27326589)
40. Blaskovich, M. A., Yendluri, V., Lawrence, H. R., Lawrence, N. J., Sebti, S. M., and Springett, G. M. (2013) Lysophosphatidic acid acyltransferase β regulates mTOR signaling. PLoS One 8, e78632
41. Dircks, L., and Sul, H. S. (1999) Acyltransferases of de novo glycerophospholipid biosynthesis. Prog. Lipid Res. 38, 461-479
42. Shulga, Y. V., Topham, M. K., and Epand, R. M. (2011) Regulation and functions of diacylglycerol kinases. Chem. Rev. 111, 6186-6208
43. Skippen, A., Jones, D. H., Morgan, C. P., Li, M., and Cockcroft, S. (2002) Mechanism of ADP ribosylation factor-stimulated phosphatidylinositol 4,5-bisphosphate synthesis in HL60 cells. J. Biol. Chem. 277, 5823-5831 (Pubitemid 34968361)
44. Pannequin, J., Delaunay, N., Darido, C., Maurice, T., Crespy, P., Frohman, M. A., Balda, M. S., Matter, K., Joubert, D., Bourgaux, J. F., Bali, J. P., and Hollande, F. (2007) Phosphatidylethanol accumulation promotes intestinal hyperplasia by inducing ZONAB-mediated cell density increase in response to chronic ethanol exposure. Mol. Cancer Res. 5, 1147-1157 (Pubitemid 350137110)
45. Emoto, M., Klarlund, J. K., Waters, S. B., Hu, V., Buxton, J. M., Chawla, A., and Czech, M. P. (2000) A role for phospholipase D in GLUT4 glucose transporter translocation. J. Biol. Chem. 275, 7144-7151 (Pubitemid 30146263)
46. Huang, P., Altshuller, Y. M., Hou, J. C., Pessin, J. E., and Frohman, M. A. (2005) Insulin-stimulated plasma membrane fusion of Glut4 glucose transporter-containing vesicles is regulated by phospholipase D1. Mol. Biol. Cell 16, 2614-2623 (Pubitemid 40741210)
47. Su, W., Yeku, O., Olepu, S., Genna, A., Park, J. S., Ren, H., Du, G., Gelb, M. H., Morris, A. J., and Frohman, M. A. (2009) 5-Fluoro-2-indolyl deschlorohalopemide (FIPI), a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis. Mol. Pharmacol. 75, 437-446
48. Sato, T., Hongu, T., Sakamoto, M., Funakoshi, Y., and Kanaho, Y. (2013) Molecular mechanisms of N-formyl-methionyl-leucyl-phenylalanineinduced superoxide generation and degranulation in mouse neutrophils: phospholipase D is dispensable. Mol. Cell. Biol. 33, 136-145
49. Liscovitch, M., Chalifa, V., Danin, M., and Eli, Y. (1991) Inhibition of neural phospholipase D activity by aminoglycoside antibiotics. Biochem. J. 279, 319-321
50. Gomez-Muñoz, A., Martin, A., O'Brien, L., and Brindley, D. N. (1994) Cell-permeable ceramides inhibit the stimulation of DNA synthesis and phospholipase D activity by phosphatidate and lysophosphatidate in rat fibroblasts. J. Biol. Chem. 269, 8937-8943
51. Nakamura, Y., Nakashima, S., Ojio, K., Banno, Y., Miyata, H., and Nozawa, Y. (1996) Ceramide inhibits IgE-mediated activation of phospholipase D, but not of phospholipase C, in rat basophilic leukemia (RBL-2H3) cells. J. Immunol. 156, 256-262 (Pubitemid 26006971)
52. Vitale, N., Caumont, A. S., Chasserot-Golaz, S., Du, G., Wu, S., Sciorra, V. A., Morris, A. J., Frohman, M. A., and Bader, M. F. (2001) Phospholipase D1: a key factor for the exocytotic machinery in neuroendocrine cells. EMBO J. 20, 2424-2434 (Pubitemid 32452860)
53. Garcia, A., Zheng, Y., Zhao, C., Toschi, A., Fan, J., Shraibman, N., Brown, H. A., Bar-Sagi, D., Foster, D. A., and Arbiser, J. L. (2008) Honokiol suppresses survival signals mediated by Ras-dependent phospholipase D activity in human cancer cells. Clin. Cancer Res. 14, 4267-4274
54. Monovich, L., Mugrage, B., Quadros, E., Toscano, K., Tommasi, R., LaVoie, S., Liu, E., Du, Z., LaSala, D., Boyar, W., and Steed, P. (2007) Optimization of halopemide for phospholipase D2 inhibition. Bioorg. Med. Chem. Lett. 17, 2310-2311 (Pubitemid 46484301)
55. Scott, S. A., Selvy, P. E., Buck, J. R., Cho, H. P., Criswell, T. L., Thomas, A. L., Armstrong, M. D., Arteaga, C. L., Lindsley, C. W., and Brown, H. A. (2009) Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. Nat. Chem. Biol. 5, 108-117
56. O'Reilly, M. C., Scott, S. A., Brown, K. A., Oguin, T. H., 3rd, Thomas, P. G., Daniels, J. S., Morrison, R., Brown, H. A., and Lindsley, C. W. (2013) Development of dual PLD1/2 and PLD2 selective inhibitors from a common 1,3,8-triazaspiro[4.5]decane core: discovery of Ml298 and Ml299 that decrease invasive migration in U87-MG glioblastoma cells. J. Med. Chem. 56, 2695-2699
57. Arun, S. N., Xie, D., Howard, A. C., Zhong, Q., Zhong, X., McNeil, P. L., and Bollag, W. B. (2013) Cell wounding activates phospholipase D in primary mouse keratinocytes. J. Lipid Res. 54, 581-591
58. Calabrese, B., Saffin, J. M., and Halpain, S. (2014) Activity-dependent dendritic spine shrinkage and growth involve downregulation of cofilin via distinct mechanisms. PLoS One 9, e94787
59. Hornberger, T. A., Chu, W. K., Mak, Y. W., Hsiung, J. W., Huang, S. A., and Chien, S. (2006) The role of phospholipase D and phosphatidic acid in the mechanical activation of mTOR signaling in skeletal muscle. Proc. Natl. Acad. Sci. U.S.A. 103, 4741-4746
60. Jaafar, R., De Larichaudy, J., Chanon, S., Euthine, V., Durand, C., Naro, F., Bertolino, P., Vidal, H., Lefai, E., and Némoz, G. (2013) Phospholipase D regulates the size of skeletal muscle cells through the activation ofmTOR signaling. Cell Commun. Signal. 11, 55
61. Kanaho, Y., Sato, T., Hongu, T., and Funakoshi, Y. (2013) Molecular mechanisms of fMLP-induced superoxide generation and degranulation in mouse neutrophils. Adv. Biol. Regul. 53, 128-134
62. Nishioka, T., Frohman, M. A., Matsuda, M., and Kiyokawa, E. (2010) Heterogeneity of phosphatidic acid levels and distribution at the plasma membrane in living cells as visualized by a Foster resonance energy transfer (FRET) biosensor. J. Biol. Chem. 285, 35979-35987
63. Norton, L. J., Zhang, Q., Saqib, K. M., Schrewe, H., Macura, K., Anderson, K. E., Lindsley, C. W., Brown, H. A., Rudge, S. A., and Wakelam, M. J. (2011) PLD1 rather than PLD2 regulates phorbol-ester-, adhesion-dependent and Fcγ-receptor-stimulated ROS production in neutrophils. J. Cell Sci. 124, 1973-1983
64. Sanematsu, F., Nishikimi, A., Watanabe, M., Hongu, T., Tanaka, Y., Kanaho, Y., Côté, J. F., and Fukui, Y. (2013) Phosphatidic acid-dependent recruitment and function of the Rac activator DOCK1 during dorsal ruffle formation. J. Biol. Chem. 288, 8092-8100
65. Tsukahara, T., Tsukahara, R., Fujiwara, Y., Yue, J., Cheng, Y., Guo, H., Bolen, A., Zhang, C., Balazs, L., Re, F., Du, G., Frohman, M. A., Baker, D. L., Parrill, A. L., Uchiyama, A., Kobayashi, T., Murakami-Murofushi, K., and Tigyi, G. (2010) Phospholipase D2-dependent inhibition of the nuclear hormone receptor PPARγ by cyclic phosphatidic acid. Mol. Cell 39, 421-432
66. Pupovac, A., Stokes, L., and Sluyter, R. (2013) CAY10593 inhibits the human P2X7 receptor independently of phospholipase D1 stimulation. Purinergic Signal. 9, 609-619
67. Henkels, K. M., Boivin, G. P., Dudley, E. S., Berberich, S. J., and Gomez-Cambronero, J. (2013) PhospholipaseD(PLD) drives cell invasion, tumor growth and metastasis in a human breast cancer xenograph model. Oncogene 32, 5551-5562
68. Lee, C. S., Kim, I. S., Park, J. B., Lee, M. N., Lee, H. Y., Suh, P. G., and Ryu, S. H. (2006) The phox homology domain of phospholipase D activates dynamin GTPase activity and accelerates EGFR endocytosis. Nat. Cell Biol. 8, 477-484
69. Gomez-Cambronero, J. (2014) Phosphatidic acid, phospholipase D and tumorigenesis. Adv. Biol. Regul. 54, 197-206
70. Toschi, A., Lee, E., Thompson, S., Gadir, N., Yellen, P., Drain, C. M., Ohh, M., and Foster, D. A. (2010) Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells. Cancer Lett. 299, 72-79
71. Nguyen, D. X., Bos, P. D., and Massagué, J. (2009) Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 9, 274-284
72. Zhang, Y., Redina, O., Altshuller, Y. M., Yamazaki, M., Ramos, J., Chneiweiss, H., Kanaho, Y., and Frohman, M. A. (2000) Regulation of expression of phospholipase D1 and D2 by PEA-15, a novel protein that interacts with them. J. Biol. Chem. 275, 35224-35232
73. Kang, D. W., Hwang, W. C., Park, M. H., Ko, G. H., Ha, W. S., Kim, K. S., Lee, Y. C., Choi, K. Y., and Min, D. S. (2013) Rebamipide abolishes Helicobacter pylori CagA-induced phospholipase D1 expression via inhibition of NFκB and suppresses invasion of gastric cancer cells. Oncogene 32, 3531-3542
74. Kang, D. W., Park, M. H., Lee, Y. J., Kim, H. S., Lindsley, C. W., Alex Brown, H., and Min do, S. (2011) Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells. Int. J. Cancer 128, 805-816
75. Kato, Y., Lambert, C. A., Colige, A. C., Mineur, P., Noël, A., Frankenne, F., Foidart, J. M., Baba, M., Hata, R., Miyazaki, K., and Tsukuda, M. (2005) Acidic extracellular pH induces matrix metalloprotei-nase- 9 expression in mouse metastatic melanoma cells through the phospholipase D-mitogen-activated protein kinase signaling. J. Biol. Chem. 280, 10938-10944 (Pubitemid 40418395)
76. Reich, R., Blumenthal, M., and Liscovitch, M. (1995) Role of phospholipase D in laminin-induced production of gelatinase A (MMP-2) in metastatic cells. Clin. Exp. Metastasis 13, 134-140
77. Mor, A., Wynne, J. P., Ahearn, I. M., Dustin, M. L., Du, G., and Philips, M. R. (2009) Phospholipase D1 regulates lymphocyte adhesion via upregulation of Rap1 at the plasma membrane. Mol. Cell. Biol. 29, 3297-3306
78. Montresor, A., Bolomini-Vittori, M., Simon, S. I., Rigo, A., Vinante, F., and Laudanna, C. (2009) Comparative analysis of normal versus CLL B-lymphocytes reveals patient-specific variability in signaling mechanisms controlling LFA-1 activation by chemokines. Cancer Res. 69, 9281-9290
79. Liu, H. Y., Lee, N., Tsai, T. Y., and Ho, S. Y. (2010) Zebrafish fat-free, a novel Arf effector, regulates phospholipase D to mediate lipid and glucose metabolism. Biochim. Biophys. Acta 1801, 1330-1340
80. Andersson, L., Boström, P., Ericson, J., Rutberg, M., Magnusson, B., Marchesan, D., Ruiz, M., Asp, L., Huang, P., Frohman, M. A., Borén, J., and Olofsson, S. O. (2006) PLD1 and ERK2 regulate cytosolic lipid droplet formation. J. Cell Sci. 119, 2246-2257
81. Colley, W. C., Altshuller, Y. M., Sue-Ling, C. K., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Branch, K. D., Tsirka, S. E., Bollag, R. J., Bollag, W. B., and Frohman, M. A. (1997) Cloning and expression analysis of murine phospholipase D1. Biochem. J. 326, 745-753 (Pubitemid 27438048)
82. Kim, H., Lee, J., Kim, S., Shin, M. K., Min do, S., and Shin, T. (2007) Differential expression of phospholipases D1 and D2 in mouse tissues. Cell. Biol. Int. 31, 148-155 (Pubitemid 46201910)
83. Morris, A. J. (2007) Regulation of phospholipase D activity, membrane targeting and intracellular trafficking by phosphoinositides. Biochem. Soc. Symp. 247-257
84. Du, G., Altshuller, Y. M., Vitale, N., Huang, P., Chasserot-Golaz, S., Morris, A. J., Bader, M. F., and Frohman, M. A. (2003) Regulation of phospholipase D1 subcellular cycling through coordination of multiple membrane association motifs. J. Cell Biol. 162, 305-315 (Pubitemid 36928843)
85. Donaldson, J. G. (2009) Phospholipase D in endocytosis and endosomal recycling pathways. Biochim. Biophys. Acta 1791, 845-849
86. Vorland, M., and Holmsen, H. (2008) Phospholipase D in human platelets: presence of isoenzymes and participation of autocrine stimulation during thrombin activation. Platelets 19, 211-224 (Pubitemid 351574443)
87. Gay, L. J., and Felding-Habermann, B. (2011) Contribution of platelets to tumour metastasis. Nat. Rev. Cancer 11, 123-134
88. Labelle, M., Begum, S., and Hynes, R. O. (2011) Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 20, 576-590
89. Chauhan, V. P., Stylianopoulos, T., Martin, J. D., Popović, Z., Chen, O., Kamoun, W. S., Bawendi, M. G., Fukumura, D., and Jain, R. K. (2012) Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner. Nat. Nanotechnol. 7, 383-388
90. Shibuya, M. (2006) Vascular endothelial growth factor (VEGF)-receptor2: its biological functions, major signaling pathway, and specific ligand VEGF-E. Endothelium 13, 63-69
91. Hanahan, D., and Weinberg, R. A. (2011) Hallmarks of cancer: the next generation. Cell 144, 646-674
92. Dall'Armi, C., Hurtado-Lorenzo, A., Tian, H., Morel, E., Nezu, A., Chan, R. B., Yu, W. H., Robinson, K. S., Yeku, O., Small, S. A., Duff, K., Frohman, M. A., Wenk, M. R., Yamamoto, A., and Di Paolo, G. (2010) The phospholipase D1 pathway modulates macroautophagy. Nat. Commun. 1, 142
93. Schmukler, E., Kloog, Y., and Pinkas-Kramarski, R. (2014) Ras and autophagy in cancer development and therapy. Oncotarget 5, 577-586
94. Pittet, J. F., Griffiths, M. J., Geiser, T., Kaminski, N., Dalton, S. L., Huang, X., Brown, L. A., Gotwals, P. J., Koteliansky, V. E., Matthay, M. A., and Sheppard, D. (2001) TGF-βis a critical mediator of acute lung injury. J. Clin. Invest. 107, 1537-1544 (Pubitemid 32574640)
95. Matthay, M. A., Clerici, C., and Saumon, G. (2002) Invited review: Active fluid clearance from the distal air spaces of the lung. J. Appl. Physiol. 93, 1533-1541
96. Peters, D. M., Vadász, I., Wujak, L., Wygrecka, M., Olschewski, A., Becker, C., Herold, S., Papp, R., Mayer, K., Rummel, S., Brandes, R. P., Günther, A., Waldegger, S., Eickelberg, O., Seeger, W., and Morty, R. E. (2014) TGF-βdirects trafficking of the epithelial sodium channel ENaC which has implications for ion and fluid transport in acute lung injury. Proc. Natl. Acad. Sci. U.S.A. 111, E374-E383
97. Romeo, Y., Zhang, X., and Roux, P. P. (2012) Regulation and function of the RSK family of protein kinases. Biochem. J. 441, 553-569
98. Ammar, M. R., Humeau, Y., Hanauer, A., Nieswandt, B., Bader, M. F., and Vitale, N. (2013) The Coffin-Lowry syndrome-associated protein RSK2 regulates neurite outgrowth through phosphorylation of phospholipase D1 (PLD1) and synthesis of phosphatidic acid. J. Neurosci. 33, 19470-19479
99. Nobis, M., Carragher, N. O., McGhee, E. J., Morton, J. P., Sansom, O. J., Anderson, K. I., and Timpson, P. (2013) Advanced intravital subcellular imaging reveals vital three-dimensional signalling events driving cancer cell behaviour and drug responses in live tissue. FEBS J. 280, 5177-5197
100. Martelli, C., Borelli, M., Ottobrini, L., Rainone, V., Degrassi, A., Russo, M., Gianelli, U., Bosari, S., Fiorini, C., Trabattoni, D., Clerici, M., and Lucignani, G. (2012) In vivo imaging of lymph node migration of MNPand 111In-labeled dendritic cells in a transgenic mouse model of breast cancer (MMTV-Ras). Mol. Imaging Biol. 14, 183-196
101. Gilbert, L. A., and Hemann, M. T. (2011) Chemotherapeutic resistance: surviving stressful situations. Cancer Res. 71, 5062-5066
102. Mead, K. I., Zheng, Y., Manzotti, C. N., Perry, L. C., Liu, M. K., Burke, F., Powner, D. J., Wakelam, M. J., and Sansom, D. M. (2005) Exocytosis of CTLA-4 is dependent on phospholipaseDandADPribosylation factor-1 and stimulated during activation of regulatory T cells. J. Immunol. 174, 4803-4811
103. Nalluri, S. R., Chu, D., Keresztes, R., Zhu, X., and Wu, S. (2008) Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis. JAMA 300, 2277-2285
104. Schwarzbach, C. J., Schaefer, A., Ebert, A., Held, V., Bolognese, M., Kablau, M., Hennerici, M. G., and Fatar, M. (2012) Stroke and cancer: the importance of cancer-associated hypercoagulation as a possible stroke etiology. Stroke 43, 3029-3034